Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis [PDF]
Globalization and Health, 2019 Background Recently, interest in compulsory licensing of pharmaceuticals has been growing regardless of a country’s income- level. We aim to investigate the use of compulsory licensing as a legitimate part of the patent system and tool for the government
Kyung-Bok Son
doaj +2 more sources
Compulsory licensing of pharmaceuticals during public health crisis: a TRIPS framework analysis [PDF]
Frontiers in Public HealthThe COVID-19 pandemic has exposed inequities in global healthcare resource allocation, reigniting debates over international intellectual property (IP) protections.
Zhanpeng Li, Peng Guo
doaj +2 more sources
The role of patent waivers and compulsory licensing in facilitating access to COVID-19 vaccines: Findings from a survey among healthcare practitioners in Nigeria [PDF]
PLOS Global Public Health, 2022 The roll out of COVID-19 vaccines has again revealed the gap between high income countries and developing nations in terms of access to healthcare commodities and services. With the slow vaccination roll out in many low income countries and the emergence
Obi Peter Adigwe, Davidson Oturu
doaj +3 more sources
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation [PDF]
Journal of Pharmaceutical Policy and Practice, 2017 The challenge of providing access to high-priced patented medicines is a global problem affecting all countries. A decade and a half ago the use of flexibilities contained in the World Trade Organization Agreement on Trade Related Aspects of Intellectual
Ellen F. M. ‘t Hoen +2 more
doaj +2 more sources
Welfare effects of compulsory licensing [PDF]
Journal of Regulatory Economics, 2015 This paper derives necessary and sufficient conditions for compulsory licensing to increase consumer surplus and total welfare, taking into account both static (technology transfer) and dynamic (innovation) effects. When the risk-free rate is low, compulsory licensing is shown unambiguously to increase consumer surplus.
Jacob Seifert
exaly +4 more sources
Compulsory licensing and access to drugs [PDF]
European Journal of Health Economics, 2014 Compulsory licensing allows the use of a patented invention without the owner's consent, with the aim of improving access to essential drugs. The pharmaceutical sector argues that, if broadly used, it can be detrimental to innovation. We model the interaction between a company in the North that holds the patent for a certain drug and a government in ...
Charitini Stavropoulou +1 more
exaly +5 more sources
Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis. [PDF]
PLoS Medicine, 2012 BackgroundIt is now a decade since the World Trade Organization (WTO) adopted the "Declaration on the TRIPS Agreement and Public Health" at its 4th Ministerial Conference in Doha. Many anticipated that these actions would lead nations to claim compulsory
Reed Beall, Randall Kuhn
doaj +2 more sources
The Legislative Approach and System Improvement of China’s Compulsory Licensing for Drug Patents [PDF]
Drug Design, Development and Therapy, 2021 Cao Z, Chen Y, Jiang W, Li W.
exaly +2 more sources
Compulsory Licensing of Pharmaceuticals in High‐Income Countries: A Comparative Analysis [PDF]
Milbank Quarterly, 2022 Anna Kaltenboeck, Peter B Bach
exaly +2 more sources
To patent or not to patent: challenges and solutions to the patent ban on new genomic techniques plant in EU [PDF]
GM Crops & FoodThe Proposal for a new Regulation on plants produced by certain new genomic techniques (NGTs) embraces the deregulation of NGT plants but introduces a patent ban on them.
Li Jiang, Mike Adcock, Hong Yang
doaj +2 more sources